What is Kardigan, Inc. Common Stock?
operates as a biopharmaceutical company focused on developing medicines for cardiovascular diseases.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
operates as a biopharmaceutical company focused on developing medicines for cardiovascular diseases. The company develops and provides a portfolio of medicines that target the underlying pathophysiology of cardiovascular diseases, including primary and secondary cardiomyopathies leading to heart failure. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 1.08B.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.
| Shares sold | Shares bought | |
|---|---|---|
| 0-3months | 0 | 0 |
| 3-6months | 0 | 35,625,000 shares $90.0M |
| 6-9months | 0 | 0 |
| 9-12months | 0 | 0 |